AzTrials
AzTrials

Bowel Preparation for ColonoscopyNCT01028573

A Study Comparing PEG-3350 (Miralax) and Gatorade With PEG-ELS (Golytely) for Bowel Preparation Prior to Colonoscopy

A study testing PEG-ELS (Golytely), Miralax mixed with Gatorade and Miralax in people with Bowel Preparation for Colonoscopy, run by Southern California Institute for Research and Education at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study to to see how well Miralax (PEG-3350) and Gatorade cleans the colon before a colonoscopy and how easy it is to take compared to Golytely (PEG-ELS) bowel preparation solution. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Bowel Preparation for Colonoscopy
What is being tested?
PEG-ELS (Golytely), Miralax mixed with Gatorade and Miralax
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteUnited States
Study dates
Nov 2009to Jul 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18-80 years in age
  • Undergoing full colonoscopy for colorectal cancer screening or colon polyp/cancer surveillance or other diagnostic purpose

Who cannot join

  • Allergic to polyethylene glycol
  • Pregnant or lactating
  • Baseline abnormalities of relevant serum electrolytes including Sodium, Potassium, Calcium, Magnesium and phosphorus
  • Congestive Heart Failure NY Heart Assn, Grades III and IV
  • Liver Cirrhosis Childs Pugh Class B or C
  • Serum Creatinine greater than 1.5
Show all 9Show fewer
  • Previous alimentary tract surgery
  • Ongoing symptoms of abdominal pain, bloating, nausea or constipation
  • Ileus, suspected bowel obstruction, toxic colitis or megacolon, severe ulcerative colitis

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • VA Long Beach Healthcare System

    Long Beach, California, 90822-5201

    Mazen Jamal, MD

    Recruiting

Other trials in United States

About this study

Official title: A Randomized, Controlled, Single-Blind Study Comparing the Efficacy, Tolerability and Safety of PEG-3350 (Miralax) and Gatorade With PEG-ELS (Golytely) for Bowel Preparation Prior to Colonoscopy

The purpose of this study to to see how well Miralax (PEG-3350) and Gatorade cleans the colon before a colonoscopy and how easy it is to take compared to Golytely (PEG-ELS) bowel preparation solution. Another purpose is to see if taking half of the bowel preparation solution on the evening before the colonoscopy and half on the morning of the colonoscopy will result in a cleaner colon than taking all of the bowel preparation solution on the evening before.

Being tested
PEG-ELS (Golytely), Miralax mixed with Gatorade, Miralax
Keywords
bowel preparation, colonoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PEG-ELS (Golytely)Drug

    4L consumed evening before colonoscopy

  • PEG-ELS (Golytely)Drug

    2L consumed on the evening before and 2L consumed on the morning of Colonoscopy

  • Miralax mixed with GatoradeDrug

    238g of PEG-3350 (Miralax) mixed with 2L of Gatorade consumed on the evening before colonoscopy

  • MiralaxDrug

    1L of PEG-3350 + Gatorade consumed on the evening before and 1L of PEG-3350 + Gatorade consumed on the morning of Colonoscopy

Study groups in NCT01028573
Study groupRoleWhat they receive
Group 1Active comparator4L of PEG-ELS (Golytely) consumed on the evening before colonoscopy
Receives: Drug: PEG-ELS (Golytely)
Group 2Experimental2L of PEG-ELS (Golytely) consumed on the evening before and 2L consumed on the morning of colonoscopy
Receives: Drug: PEG-ELS (Golytely)
Group 3Experimental238g of PEG-3350 mixed with 2L of Gatorade
Receives: Drug: Miralax mixed with Gatorade
Group 4Experimental1L of PEG-3350 + Gatorade
Receives: Drug: Miralax

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of bowel prepreparation/cleanliness scored using the Boston Bowel Preparation Scale

    Measured: two years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2009 (estimated)
  2. Study startNov 2009
  3. Primary completionJul 2012 (estimated)
  4. Study completionJul 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01028573
Sponsor's protocol ID
976
Status last verified
Mar 2012
First submitted
7 Dec 2009
Last updated
14 Mar 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing PEG-ELS (Golytely), Miralax mixed with Gatorade and Miralax in people with Bowel Preparation for Colonoscopy, run by Southern California Institute for Research and Education at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Mar 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mazen Jamal, MD ((562) 826-5628, mazen.jamal@va.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of bowel prepreparation/cleanliness scored using the Boston Bowel Preparation Scale (time frame: two years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in